- Home
- BIRK vs ASND Comparison
BIRK vs ASND Comparison
Compare BIRK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIRK
- ASND
- Stock Information
- Founded
- BIRK 1774
- ASND 2006
- Country
- BIRK United Kingdom
- ASND Denmark
- Employees
- BIRK N/A
- ASND N/A
- Industry
- BIRK
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- BIRK
- ASND Health Care
- Exchange
- BIRK Nasdaq
- ASND Nasdaq
- Market Cap
- BIRK 9.4B
- ASND 7.7B
- IPO Year
- BIRK 2023
- ASND 2015
- Fundamental
- Price
- BIRK $47.04
- ASND $123.00
- Analyst Decision
- BIRK Buy
- ASND Strong Buy
- Analyst Count
- BIRK 20
- ASND 13
- Target Price
- BIRK $60.79
- ASND $195.92
- AVG Volume (30 Days)
- BIRK 938.2K
- ASND 391.4K
- Earning Date
- BIRK 08-29-2024
- ASND 11-05-2024
- Dividend Yield
- BIRK N/A
- ASND N/A
- EPS Growth
- BIRK N/A
- ASND N/A
- EPS
- BIRK 0.63
- ASND N/A
- Revenue
- BIRK $1,846,639,880.00
- ASND $340,327,869.00
- Revenue This Year
- BIRK $22.13
- ASND $16.12
- Revenue Next Year
- BIRK $17.29
- ASND $87.44
- P/E Ratio
- BIRK $75.71
- ASND N/A
- Revenue Growth
- BIRK 19.77
- ASND 166.54
- 52 Week Low
- BIRK $37.98
- ASND $86.55
- 52 Week High
- BIRK $64.78
- ASND $161.00
- Technical
- Relative Strength Index (RSI)
- BIRK 41.41
- ASND 39.09
- Support Level
- BIRK $46.84
- ASND $124.02
- Resistance Level
- BIRK $50.30
- ASND $133.97
- Average True Range (ATR)
- BIRK 1.15
- ASND 3.67
- MACD
- BIRK -0.19
- ASND -0.33
- Stochastic Oscillator
- BIRK 23.31
- ASND 15.18
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. The company operates in four operating segments based on its regional hubs: Americas, Europe and APMA (Asia Pacific, Middle East and Africa). The company sells its products through two main channels: business-to-business (B2B) and direct-to-consumer (DTC).
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.